查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1994299

去除异物器材市场：2026-2032年全球市场预测（依产品类型、入路、治疗类型、应用、通路和最终用户划分）

Foreign Body Removal Device Market by Product Type, Access Route, Procedure Type, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，去除异物设备市场价值将达到 36.5 亿美元，到 2026 年将成长至 39 亿美元，到 2032 年将达到 62.6 亿美元，复合年增长率为 7.99%。

主要市场统计数据
基准年 2025 36.5亿美元
预计年份：2026年 39亿美元
预测年份 2032 62.6亿美元
复合年增长率 (%) 7.99%

对临床需求、程序创新和经济压力如何改变人们对去除异物装置的期望进行清晰的背景说明。

从心臟病学到泌尿系统，去除异物装置在现代微创和影像引导治疗中发挥核心作用。该领域已从笨重的一次性器械发展成为功能多样、精准高效的系统，优先考虑患者安全、手术效率以及与更多入路方式的兼容性。近期技术进步显着提升了视觉化效果、能量控制和使用者操作体验，使临床医生能够以更小的创伤和更短的恢復时间处理日益复杂的病例。

影像技术的进步、能量模式的整合以及手术环境的变化如何重新定义产品设计、部署和商业策略。

去除异物器材的市场格局正经历一场变革，这主要得益于技术、临床和操作趋势的融合。首先，影像和导航技术的进步使得更小巧、更精准的器械成为可能，从而减少对周围组织的损伤，并提高取出成功率。其次，整合影像技术的进一步发展，例如内视镜可视性的提升和即时透视影像迭加，重新定义了内视镜和经血管手术的技术可行性范围。

评估美国关税调整到 2025 年对供应链、采购和商业性公平的多方面营运和策略影响。

美国在2025年前逐步实施的关税政策，为去除异物设备及其零件供应商带来了新的挑战。关税的影响因医疗设备类型和供应链的不同而有所差异，进而影响原材料和关键子组件（例如成像感测器、精密马达和特殊合金）的采购选择。为此，一些製造商正在加速供应商多元化和近岸外包策略，以规避关税波动对生产计画的影响，并控制敏感临床应用的前置作业时间。

一种基于细分市场的、精细的观点，将产品模式、临床用途和销售管道偏好与差异化的开发和商业化重点相结合。

细分市场的趋势揭示了临床需求、技术成熟度和购买行为的交汇点，这些因素共同塑造了机会和风险。基于产品类型，本文分析了冷冻消融、电外科、雷射和超音波技术的市场趋势。冷冻消融术进一步细分为接触式和非接触式，电外科细分为双极式和单极式，雷射细分为二氧化碳雷射、二极体雷射和Nd:YAG激光，超音波细分为高频和低频产品组。每种产品的发展路径都展现出独特的特征。冷冻消融因其在精细解剖区域具有组织保护作用而备受青睐；电外科系统因其在有限空间内的止血效果和快速操作而受到青睐；激光因其在纤维组织和瘢痕组织中的精准性而备受青睐；超音波技术则能够在最大限度减少热扩散的同时实现精准切口。

区域比较分析突显了监管、医疗服务模式和基础设施的细微差异如何影响部署和市场进入策略。

不同地区的法规结构、医疗服务模式以及微创医疗设备创新应用率差异显着。在美洲，实证医学的应用正在加速推进，这得益于医疗体系优先考虑手术效果、明确的报销机制以及完善的医院采购流程。在这种环境下，能够缩短住院时间并展现可重复临床效益的医疗设备备受青睐。在欧洲、中东和非洲，由于支付系统和基础设施的差异，微创医疗器材的应用路径各不相同。一些市场正在迅速采用先进的内视镜解决方案，而其他市场则优先考虑成本控制和基本可及性，这需要灵活的服务模式和分阶段的产品交付。在亚太地区，对先进手术能力的快速投资以及门诊设施的增加，推动了对能够处理大量患者并满足不断变化的监管要求的紧凑型多功能平台的需求。

深入剖析竞争策略，揭示技术合作、模组化设计和差异化服务模式如何重新定义竞争优势。

去除异物器材领域的竞争趋势体现在对差异化平台的集中投资、与影像和导航设备供应商的策略合作以及针对性临床证据的累积。主要企业正投入研发资源，致力于提升器械的易用性、缩短手术时间并拓展其临床应用范围，并经常与领先的临床中心合作，加速迭代式设计改进。同时，一些企业正在探索模组化产品架构，以实现分阶段升级并与现有手术系统互通，从而降低医院和门诊的采购门槛。

为製造商和相关人员提供切实可行的策略指导，以推动稳健的产品开发、证据产生和符合实际情况的商业性执行。

产业领导企业应推动一系列切实可行的倡议，将洞察转化为市场优势。首先，他们应优先考虑支援多种能量模式和模组化晶片的互通平台设计，以满足多样化的临床需求，并缩短相邻适应症的研发週期。其次，他们应透过供应商多元化、关键零件近岸外包以及建立策略性库存缓衝来建立具有韧性的供应链，从而降低关税导致的成本和前置作业时间波动风险。第三，他们应投资产生与最终用户关键需求（给药时间、安全性结果和再处理效率）相符的针对性临床证据，以便采购委员会能够清楚地了解其相对价值。

对实证研究途径进行透明的解释，该方法结合了文献综述、专家访谈和三角验证，以支持研究结果和建议。

本分析的调查方法结合了系统性的二手资料研究、有针对性的原始资料研究和严谨的检验。二级资讯来源包括同行评审的临床文献、公开的监管文件、技术白皮书和医疗设备使用说明书，这些资料用于确定该技术的基准特征和临床性能声明。原始资料研究包括对循环系统、胃肠科、整形外科和泌尿系统的临床医生进行结构化访谈，以及与医院采购经理、门诊手术管理人员和医疗设备工程师进行讨论，以了解实际的优先事项和运营限制。

简洁地总结道，创新、营运韧性和有针对性的商业化决定了哪些解决方案能够取得持久的临床和商业性成功。

总之，目前去除异物器材市场正处于操作性创新阶段，手术精准度、供应链韧性和商业性可行性将决定竞争格局。影像和能量传输技术的进步使临床医生能够更安全、更有效率地应对复杂的异物取出挑战。同时，诸如转向门诊治疗和更严格的感染控制标准等营运模式的改变正在影响产品需求。到2025年，收费系统趋于稳定，这使得供应链的灵活性和成本控制的设计选择成为持续的挑战，也使得策略采购和近市场组装比以往任何时候都更加重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：去除异物设备市场：依产品类型划分

  • 冷冻消融
    • 联繫类型
    • 非接触式
  • 用于电外科手术
    • 双极
    • 单极
  • 雷射
    • CO2
    • 二极体
    • Nd：YAG
  • 超音波
    • 高频
    • 低频

第九章：依接取通路分類的去除异物设备市场进入

  • 内视镜
  • 经皮
  • 血管内

第十章：去除异物设备市场（依处理类型划分）

  • 用于诊断
  • 治疗

第十一章：去除异物设备市场：依应用领域划分

  • 循环系统
  • 消化系统
  • 整形外科
  • 泌尿系统

第十二章：去除异物设备市场：依通路划分

  • 直销
  • 销售代理
  • 在线的

第十三章：去除异物设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十四章：去除异物设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：去除异物设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：去除异物设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国去除异物设备市场

第十八章：中国去除异物设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Ambu A/S
  • Applied Medical Resources Corporation
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cantel Medical Corporation
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical Incorporated
  • Endo International plc
  • Fujifilm Holdings Corporation
  • Intuitive Surgical Inc
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Laborie Medical Technologies Inc
  • Medtronic plc
  • Nipro Corporation
  • Olympus Corporation
  • Pentax Medical（HOYA Corporation）
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-1A1A064C0543

The Foreign Body Removal Device Market was valued at USD 3.65 billion in 2025 and is projected to grow to USD 3.90 billion in 2026, with a CAGR of 7.99%, reaching USD 6.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.65 billion
Estimated Year [2026] USD 3.90 billion
Forecast Year [2032] USD 6.26 billion
CAGR (%) 7.99%

A clear contextual overview of how clinical demand, procedural innovation, and economic pressures are reshaping device expectations in foreign body removal

Foreign body removal devices are central to modern minimally invasive and image-guided interventions, spanning clinical specialties from cardiology to urology. The field has evolved from bulky, single-purpose instruments to versatile, precision-focused systems that emphasize patient safety, procedural efficiency, and compatibility with a broader range of access routes. Recent technological advances have enhanced visualization, energy delivery control, and user ergonomics, enabling clinicians to manage increasingly complex cases with less trauma and shorter recovery times.

Clinicians and procurement teams now evaluate devices not only on technical performance but also on lifecycle economics, sterility profiles, and integration with hospital workflows. With ambulatory surgery centers growing in scope and hospitals prioritizing throughput, device developers must balance reusability with single-use convenience while ensuring regulatory compliance and robust clinical evidence. As a result, product roadmaps are aligning more closely with real-world procedural needs and reimbursement realities.

This introduction frames the subsequent analysis by highlighting the drivers shaping adoption and investment. It emphasizes clinical demand for precision removal across endoscopic, percutaneous, and transvascular routes, the importance of interoperable imaging and navigation, and the competitive necessity for manufacturers to demonstrate clear value through outcomes, ease of use, and total cost of ownership.

How imaging advances, energy modality convergence, and procedural setting shifts are jointly redefining product design, deployment, and commercial strategy

The landscape for foreign body removal devices is undergoing transformative shifts driven by converging technological, clinical, and operational trends. First, imaging and navigation improvements are enabling smaller, more precise instruments that reduce collateral tissue damage and improve retrieval success rates. Advances in integrated imaging, including enhanced endoscopic visualization and real-time fluoroscopic overlays, have redefined what is technically feasible during endoscopic and transvascular procedures.

Second, energy-based modalities are evolving; cryoablation, electrosurgical systems, lasers, and ultrasonic technologies are each becoming more adaptable to hybrid procedural workflows. These modalities are being refined for targeted interaction with foreign materials while preserving surrounding tissue, and innovations in energy control and sensor feedback are improving clinician confidence. Consequently, device designers are focusing on modular platforms that can support multiple energy types or interchangeable tips to address diverse clinical needs.

Third, regulatory focus and infection-prevention priorities are accelerating adoption of disposables and single-use components, yet they coexist with sustainability concerns that push manufacturers to justify reusable platforms through validated reprocessing workflows. Reimbursement pathways and procedural coding updates are also encouraging migration of certain cases to ambulatory settings, affecting device form factors and sterilization expectations. Altogether, these shifts favor solutions that combine procedural precision, streamlined workflows, and demonstrable safety, prompting strategic redirection across the development, commercialization, and service models of device makers.

Assessing the multifaceted operational and strategic consequences of United States tariff adjustments through 2025 on supply chains, sourcing, and commercial parity

The imposition and evolution of tariffs in the United States through 2025 have introduced a new layer of complexity for suppliers of foreign body removal devices and their component ecosystems. Tariff impacts have been heterogeneous across device types and supply chains, influencing the sourcing choices of raw materials and critical subassemblies such as imaging sensors, precision motors, and specialized alloys. In response, some manufacturers have accelerated supplier diversification and nearshoring strategies to insulate production timelines from tariff volatility and to control lead times for sensitive clinical deployments.

Tariff-driven cost pressure has prompted firms to reassess pricing structures and to seek efficiencies through design simplification, consolidation of bill-of-materials, and greater vertical integration of high-risk components. Simultaneously, procurement teams at hospitals and ambulatory centers are more closely scrutinizing total cost implications, opening opportunities for suppliers that can demonstrate cost stability, predictable logistics, and clear clinical value. This dynamic has also heightened interest in modular solutions that enable localized assembly or final configuration, reducing cross-border flows of finished goods subject to duty.

Moreover, tariff policy uncertainty has influenced investment decisions, with some development timelines pushed to accommodate contingency planning and dual-source validation. Regulatory submission pathways and supply documentation requirements have consequently become more prominent considerations during product development, as manufacturers respond to both customs scrutiny and the clinical imperative to maintain uninterrupted device availability.

A nuanced segmentation-driven view that aligns product modalities, clinical applications, and channel preferences with differentiated development and commercialization priorities

Segment-specific dynamics reveal where clinical need, technology readiness, and purchasing behavior intersect to shape opportunity and risk. Based on product type, the landscape is studied across cryoablation, electrosurgical, laser, and ultrasonic technologies; cryoablation is further differentiated into contact and noncontact modalities, electrosurgical into bipolar and monopolar configurations, laser into CO2, diode, and Nd:YAG variants, and ultrasonic into high-frequency and low-frequency offerings. Each product pathway shows distinct trajectories: cryoablation variants are valued for tissue-sparing control in sensitive anatomical sites, electrosurgical systems are prized for haemostasis and speed in constrained workspaces, lasers are selected for precision in fibrotic or scarred tissue, and ultrasonic approaches deliver fine dissection with minimized thermal spread.

Based on application, clinical demand spans cardiovascular, gastrointestinal, orthopedic, and urological procedures, with each therapeutic area prioritizing different performance attributes and access routes. Cardiovascular interventions stress compatibility with transvascular access and intracardiac visualization, gastrointestinal procedures emphasize endoscopic maneuverability and atraumatic grasping, orthopedic cases require robust mechanical interactions for hard-tissue retrieval, and urological applications balance flexibility with irrigation and visibility in confined lumens. Based on end user, adoption patterns differ across ambulatory surgery centers, clinics, and hospitals; ambulatory settings favor compact, cost-efficient solutions that shorten turnover times, clinics emphasize outpatient convenience and workflow simplicity, and hospitals prioritize robust functionality, interoperability with imaging suites, and comprehensive service agreements.

Based on access route, the market is analyzed for endoscopic, percutaneous, and transvascular modalities, where instrument size, visualization, and device durability become critical differentiators. Based on distribution channel, direct, distributor, and online pathways influence go-to-market strategies and after-sales service expectations, shaping the degree of local support and clinical training offered. Based on procedure type, diagnostic and therapeutic workflows impose different regulatory documentation and clinician-training needs, influencing product labeling and commercial emphasis. Taken together, these segmentation lenses clarify where manufacturers should prioritize R&D, clinical studies, and commercialization investments to align with the varied technical and operational requirements across clinical settings and geographies.

Comparative regional analysis highlighting how regulatory nuance, healthcare delivery models, and infrastructure variance shape adoption and go-to-market tactics

Regional dynamics vary considerably in their regulatory frameworks, healthcare delivery models, and adoption velocity for minimally invasive device innovations. In the Americas, there is strong momentum for evidence-based adoption driven by healthcare systems that emphasize procedural outcomes, reimbursement clarity, and robust hospital procurement processes; this environment rewards devices that reduce length of stay and demonstrate reproducible clinical benefits. In Europe, Middle East & Africa, heterogeneity in payer systems and infrastructure creates mixed adoption pathways, with some markets rapidly embracing advanced endoscopic solutions while others prioritize cost containment and basic accessibility, generating a need for adaptable service models and tiered product offerings. In Asia-Pacific, rapid investment in advanced procedural capabilities and growing numbers of ambulatory facilities are increasing demand for compact, versatile platforms that can serve high volumes while meeting evolving regulatory expectations.

Across these regions, regional regulatory nuances, reimbursement timelines, and local manufacturing incentives influence partner selection and go-to-market sequencing. Transitioning between regions requires careful alignment of clinical evidence packages with local standards and a calibrated commercial approach that balances direct engagement with distributor ecosystems. Furthermore, regional supply-chain resilience and logistics capabilities vary, making tariff exposure and inventory planning particularly salient for multinational launches and regional production footprints.

Insight into competitive strategies showing how technology partnerships, modular design, and differentiated service models are redefining competitive advantage

Competitive dynamics in foreign body removal devices are characterized by focused investment in differentiated platforms, strategic partnerships with imaging and navigation providers, and targeted clinical evidence generation. Leading firms are allocating R&D resources to improve usability, reduce procedure time, and expand the clinical envelope of their devices, frequently collaborating with clinical centers of excellence to accelerate iterative design improvements. At the same time, some companies are pursuing modular product architectures that allow for incremental upgrades and cross-compatibility with existing procedural suites, thereby lowering procurement friction for hospitals and ambulatory centers.

Business models are also diversifying: while direct sales remain important for high-touch hospital accounts, distributors and digital channels are gaining traction for commodity components and single-use accessories, offering broader reach for mid-sized suppliers. After-sales services, training programs, and managed maintenance agreements are becoming differentiators that can lock in long-term relationships and reduce total cost concerns for end users. Additionally, merger and acquisition activity and licensing agreements are shaping the competitive field by enabling faster entry into new therapy areas or by securing proprietary technologies, such as advanced imaging sensors or energy-delivery mechanisms.

In this context, companies that combine clinical credibility, dependable supply operations, and flexible commercial models are best positioned to capture sustained clinician preference and institutional adoption.

Actionable strategic guidance for manufacturers and stakeholders to drive resilient product development, evidence generation, and tailored commercial execution

Industry leaders should pursue a pragmatic set of actions to convert insight into market advantage. First, prioritize interoperable platform design that supports multiple energy modalities and modular tips to meet diverse clinical needs while shortening development cycles for adjacent indications. Second, build resilient supply chains through supplier diversification, nearshoring of critical components, and strategic inventory buffers to mitigate tariff-driven cost and lead-time volatility. Third, invest in targeted clinical evidence generation that aligns with key end-user priorities-procedure time, safety outcomes, and reprocessing efficiency-so that procurement committees can clearly see comparative value.

Next, tailor commercialization approaches by region and end-user: offer compact, cost-efficient platforms and streamlined service for ambulatory settings, while providing comprehensive training and integration support for hospital suites. Strengthen distributor and online channel relationships to extend reach for consumables and single-use items, but maintain direct engagement for high-value accounts where clinical training and rapid service response are decisive. Finally, embed sustainability and reprocessing validation where feasible to address environmental concerns without compromising infection prevention. Taken together, these steps create a cohesive approach that aligns product development, regulatory strategy, and commercial execution with evolving clinical and payer expectations.

A transparent description of the evidence-based research approach combining literature review, expert interviews, and triangulation to substantiate insights and recommendations

The research methodology underpinning this analysis combined systematic secondary research with targeted primary inputs and rigorous triangulation. Secondary sources included peer-reviewed clinical literature, publicly available regulatory filings, technical white papers, and device instruction-for-use documentation to establish baseline technology characteristics and clinical performance claims. Primary research incorporated structured interviews with practicing clinicians across cardiovascular, gastrointestinal, orthopedic, and urological specialties, as well as discussions with hospital procurement leaders, ambulatory surgery administrators, and device engineers to capture real-world priorities and operational constraints.

Data synthesis followed a triangulation approach, reconciling insights from literature, expert interviews, and device specifications to ensure consistency and to surface divergent perspectives. The analysis evaluated product pipelines, access-route preferences, and distribution channel behavior through an evidence-first lens, emphasizing reproducibility and contextual validation. Quality controls included source verification, cross-referencing of clinical claims with procedural guidelines, and sensitivity checks around supply-chain and tariff-related scenarios to ensure the resulting recommendations are robust and practically actionable for decision-makers.

A concise synthesis emphasizing how innovation, operational resilience, and targeted commercialization will determine which solutions achieve durable clinical and commercial success

In conclusion, the foreign body removal device landscape is experiencing a period of pragmatic innovation where procedural precision, supply-chain resilience, and commercial adaptability determine competitive outcomes. Technological advances in imaging and energy delivery are enabling clinicians to tackle complex retrieval challenges with greater safety and efficiency, while operational shifts toward ambulatory care and heightened infection-prevention standards are altering product requirements. Tariff dynamics through 2025 have introduced a persistent need for supply-chain agility and cost-conscious design choices, making strategic sourcing and near-market assembly more relevant than ever.

Manufacturers that align modular design, focused clinical evidence, and regionally calibrated commercialization models will be best placed to meet diverse end-user needs and to reduce procurement friction. Equally, companies that couple robust after-sales support with effective training programs can secure preference in high-touch hospital environments and expand adoption in ambulatory settings. Ultimately, the intersection of clinical performance, operational reliability, and commercial clarity will determine which solutions succeed in delivering consistent clinical outcomes and sustained institutional adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Foreign Body Removal Device Market, by Product Type

  • 8.1. Cryoablation
    • 8.1.1. Contact
    • 8.1.2. Noncontact
  • 8.2. Electrosurgical
    • 8.2.1. Bipolar
    • 8.2.2. Monopolar
  • 8.3. Laser
    • 8.3.1. CO2
    • 8.3.2. Diode
    • 8.3.3. Nd:YAG
  • 8.4. Ultrasonic
    • 8.4.1. High-Frequency
    • 8.4.2. Low-Frequency

9. Foreign Body Removal Device Market, by Access Route

  • 9.1. Endoscopic
  • 9.2. Percutaneous
  • 9.3. Transvascular

10. Foreign Body Removal Device Market, by Procedure Type

  • 10.1. Diagnostic
  • 10.2. Therapeutic

11. Foreign Body Removal Device Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Gastrointestinal
  • 11.3. Orthopedic
  • 11.4. Urological

12. Foreign Body Removal Device Market, by Distribution Channel

  • 12.1. Direct
  • 12.2. Distributor
  • 12.3. Online

13. Foreign Body Removal Device Market, by End User

  • 13.1. Ambulatory Surgery Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Foreign Body Removal Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Foreign Body Removal Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Foreign Body Removal Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Foreign Body Removal Device Market

18. China Foreign Body Removal Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Ambu A/S
  • 19.7. Applied Medical Resources Corporation
  • 19.8. Becton Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Cantel Medical Corporation
  • 19.11. Coloplast A/S
  • 19.12. ConMed Corporation
  • 19.13. Cook Medical Incorporated
  • 19.14. Endo International plc
  • 19.15. Fujifilm Holdings Corporation
  • 19.16. Intuitive Surgical Inc
  • 19.17. Johnson & Johnson
  • 19.18. Karl Storz SE & Co. KG
  • 19.19. Laborie Medical Technologies Inc
  • 19.20. Medtronic plc
  • 19.21. Nipro Corporation
  • 19.22. Olympus Corporation
  • 19.23. Pentax Medical (HOYA Corporation)
  • 19.24. Richard Wolf GmbH
  • 19.25. Smith & Nephew plc
  • 19.26. STERIS plc
  • 19.27. Stryker Corporation
  • 19.28. Teleflex Incorporated
  • 19.29. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CONTACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CONTACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CONTACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY NONCONTACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY NONCONTACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY NONCONTACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY BIPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY BIPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY BIPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY MONOPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY MONOPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY MONOPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CO2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CO2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CO2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ND:YAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ND:YAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ND:YAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HIGH-FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HIGH-FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HIGH-FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LOW-FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LOW-FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LOW-FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY TRANSVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY TRANSVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY TRANSVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 202. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 203. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 233. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 234. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 236. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 246. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 247. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)